Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Cancers (Basel). 2021 Oct 30;13(21):5472. doi: 10.3390/cancers13215472.
Cancers (Basel). 2021.
PMID: 34771635
Free PMC article.
Targeting BRAF and RAS in Colorectal Cancer.
Bellio H, Fumet JD, Ghiringhelli F.
Bellio H, et al.
Cancers (Basel). 2021 May 3;13(9):2201. doi: 10.3390/cancers13092201.
Cancers (Basel). 2021.
PMID: 34063682
Free PMC article.
Review.
Item in Clipboard
Small Cell Neuroendocrine Carcinoma of the Paranasal Sinuses with Unexpected Location and Clinical Presentation and Occupational Exposure: A Case Report.
Tankere P, Zanetta S, Kaderbhai CG, Bellio H, Lagrange A, Garcier M, Ghiringhelli F.
Tankere P, et al. Among authors: bellio h.
Am J Case Rep. 2022 Mar 2;23:e934980. doi: 10.12659/AJCR.934980.
Am J Case Rep. 2022.
PMID: 35232952
Free PMC article.
Item in Clipboard
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Reda M, Macaire P, Bellio H, Uwer L, Ilie S, Lorgis V, Hennequin A, Ladoire S, Rederstorff E, Fumoleau P, Isambert N, Bonnin N, You B, Freyer G, Desmoulins I, Schmitt A.
Reda M, et al. Among authors: bellio h.
Cancer Chemother Pharmacol. 2022 Feb;89(2):197-208. doi: 10.1007/s00280-021-04395-y. Epub 2022 Jan 8.
Cancer Chemother Pharmacol. 2022.
PMID: 34997290
Item in Clipboard
[New drug approval: Nivolumab for adjuvant treatment of patients with PD-L1-positive (≥1%), muscle invasive urothelial carcinoma who are at high risk of recurrence after radical resection].
Bellio H, Benderra MA.
Bellio H, et al.
Bull Cancer. 2022 Oct;109(10):992-993. doi: 10.1016/j.bulcan.2022.05.006. Epub 2022 Aug 19.
Bull Cancer. 2022.
PMID: 35995615
French.
No abstract available.
Item in Clipboard
Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy.
Desmoulins I, Bellio H, Méjean N, Truntzer C, Ladoire S.
Desmoulins I, et al. Among authors: bellio h.
Eur J Cancer. 2023 Jul;187:161-163. doi: 10.1016/j.ejca.2023.03.030. Epub 2023 May 9.
Eur J Cancer. 2023.
PMID: 37167763
No abstract available.
Item in Clipboard
Cite
Cite